premenstural syndrome. Premenstrual tension syndrome
Conditions
Interventions
Intervention 1: Primerose oil capsule, 1500 mg/day (500 mg, TDS ) for 12 weeks. Intervention 2: Placebo capsule (TDS) for 12 weeks.
Treatment - Drugs
Placebo
Primerose oil capsule, 1500 mg/day (500 mg, TDS ) for 12 weeks
Placebo capsule (TDS) for 12 weeks
Sponsors
Razi Herbal Drugs Research Center, Deputy of Research and Information Technology, Lorestan Universit
Eligibility
Sex/Gender
Female
Age
18 Years to 35 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Age 18 - 35, having regular menstrual cycles with intervals 24 - 35 days , Without any physical diseases or specific drugs use, Analgesia drug for relieving pain , no record of mental diseases specially Depression disorder, no use of any anti depressants or hormonal drugs, no specific diet, no experience of stressful event during last 3 month from the beginning of the study and during the study Exclusion criteria: Occurrence of the event during the study, having physical or mental diseases, pregnancy, lactation, menstrual cycle irregularity, medical diseases, using hormonal method of contraception
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intensity of the premenstrual syndrome. Timepoint: monthly during a period of 3 months. Method of measurement: The determination of total grade ( for any symptom from 0-10 ). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMandana Saki
Lorestan University of Medical Sciences
Outcome results
None listed